Novo Nordisk’s bispecific antibody Mim8 prevented bleeding events and caused no adverse safety events in the Phase III FRONTIER3 trial. The company plans to file for approval this year, hoping to ...
Dan Roche and Joe Weil discuss the upcoming battle for second between the two young players if the team does not sign Alex Bregman.
"There isn’t enough being done – regardless of whether you’re an islander or mainlander. People feel left behind," the IFA's ...
Roche Bobois debuts at Royalmount in Montreal, offering a 6,300 sq. ft. showroom with custom furnishings, 3D design services, ...
Custom duty waiver for expensive cancer drugs doesn't address high prices due to patent monopolies, offering minimal relief ...
The Fergus girls basketball team earned their second conference win of the season with a home victory over Sidney on Saturday, Feb. 1. Kiya Foran had a strong shooting night ...
Residents have been invited to participate in a series of engaging events as the Bermuda College focuses on science next week ...
Novo Nordisk's hemophilia A drug Mim8 shows success in pediatric trial, Mim8 could compete with Roche's Hemlibra, with plans for regulatory filing this year.
In June, it was revealed that the 72-year-old NFL coach was dating Jordon Hudson, who is 24. The couple made their first red ...
Genentech has shared positive data from the Phase III REGENCY trial with regulators in the US and EU. Roche’s subsidiary ...
The countdown to Super Bowl LIX between the Kansas City Chiefs and Philadelphia Eagles has begun! Join us for the latest ...
John Dobson has made several changes to the Stormers backline for Saturday’s @Vodacom #URC clash against the Vodacom Bulls at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results